REFERENCES
  1. Preger, A., Wei, R., Berg, B., & Golomb, B. A. (2023). COVID-19-associated rhabdomyolysis: A scoping review. International Journal of Infectious Diseases, 136, 115–126. https://doi.org/10.1016/j.ijid.2023.09.002
  2. Stanley, M., Chippa, V., Aeddula, N. R., Rodriguez, B. S. Q., & Adigun, R. (2023). Rhabdomyolysis. StatPearls. https://www.ncbi.nlm.nih.gov/books/NBK448168/
  3. Giannoglou, G. D., Chatzizisis, Y. S., & Misirli, G. (2006).The syndrome of rhabdomyolysis: Pathophysiology and diagnosis . https://doi.org/10.1016/j.ejim.2006.09.020
  4. Valiyil, R., & Christopher-Stine, L. (2010). Drug-related Myopathies of Which the Clinician Should Be Aware. Current Rheumatology Reports , 12 (3), 213. https://doi.org/10.1007/S11926-010-0104-3
  5. Khan FY. Rhabdomyolysis: a review of the literature. Neth J Med. 2009 Oct;67(9):272-83. PMID: 19841484.
  6. Bawor, M., Sairam, S., Rozewicz, R., Viegas, S., Comninos, A. N., & Abbara, A. (2022). Rhabdomyolysis after COVID-19 Infection: A Case Report and Review of the Literature. Viruses , 14 (10). https://doi.org/10.3390/V14102255
  7. Tram, N., Chiodini, B., Montesinos, I., Vicinanza, A., Beretta-Piccoli, X., Gubbelmans, N., Demey, M., Genis, N., Tilmanne, A., Smeesters, P. R., & Ismaili, K. (2020). Rhabdomyolysis and Acute Kidney Injury as Leading COVID-19 Presentation in an Adolescent.Pediatric Infectious Disease Journal , 39 (10), E314–E315. https://doi.org/10.1097/INF.0000000000002853
  8. Anwar, M. Y., & Gupta, V. (2023). Myoglobinuria. StatPearls . https://www.ncbi.nlm.nih.gov/books/NBK557379/
  9. Zutt, R., van der Kooi, A. J., Linthorst, G. E., Wanders, R. J. A., & de Visser, M. (2014). Rhabdomyolysis: Review of the literature.Neuromuscular Disorders , 24 (8), 651–659. https://doi.org/10.1016/j.nmd.2014.05.005
  10. Hebert, J. F., Burfeind, K. G., Malinoski, D., & Hutchens, M. P. (2023). Molecular Mechanisms of Rhabdomyolysis-Induced Kidney Injury: From Bench to Bedside. Kidney International Reports ,8 (1), 17. https://doi.org/10.1016/J.EKIR.2022.09.026
  11. Abed, W., Abujbara, M., Batieha, A., & Ajlouni, K. (2022). Statin Induced Myopathy Among Patients Attending the National Center for Diabetes, endocrinology, & genetics. Annals of Medicine and Surgery , 74 , 103304. https://doi.org/10.1016/J.AMSU.2022.103304
  12. Maltz, H. C., Balog, D. L., & Cheigh, J. S. (1999). Rhabdomyolysis associated with concomitant use of atorvastatin and cyclosporine.The Annals of Pharmacotherapy , 33 (11), 1176–1779. https://doi.org/10.1345/APH.19039
  13. Moinuddin, I. A. (2020). Suspected Levetiracetam-Induced Rhabdomyolysis: A Case Report and Literature Review. The American Journal of Case Reports , 21 , e926064-1. https://doi.org/10.12659/AJCR.926064
  14. Kubota, K., Yamamoto, T., Kawamoto, M., Kawamoto, N., & Fukao, T. (2017). Levetiracetam-induced rhabdomyolysis: A case report and literature review. Neurology Asia , 22 (3), 275–278.
  15. Salehi, N., Agoston, E., Munir, I., & Thompson, G. J. (2017). Rhabdomyolysis in a Patient with Severe Hypothyroidism. The American Journal of Case Reports , 18 , 912. https://doi.org/10.12659/AJCR.904691
  16. Packard, K., Price, P., & Hanson, A. (2014). Antipsychotic use and the risk of rhabdomyolysis. Journal of Pharmacy Practice ,27 (5), 501–512. https://doi.org/10.1177/0897190013516509
  17. Tiglis, M., Hurmuzache, T., Bologa, C., Neagu, T. P., Mirea, L., & Grintescu, I. M. (2020). Rhabdomyolysis-Induced Acute Renal Injury in a Schizophrenic Patient. The Journal of Critical Care Medicine ,6 (4), 249. https://doi.org/10.2478/JCCM-2020-0032
  18. Kutlu, A., Songür, Ç. Y., & Apa, H. (2023). Aripiprazole-Associated Rhabdomyolysis in a 17-Year-Old Male. Archives of Iranian Medicine , 26 (1), 50. https://doi.org/10.34172/AIM.2023.08
  19. Look, M. L., Boo, Y. L., Chin, P. W., & Hoo, F. K. (2017). Risperidone-Associated Rhabdomyolysis Without Neuroleptic Malignant Syndrome: A Case Report. Journal of Clinical Psychopharmacology , 37 (1), 105–106. https://doi.org/10.1097/JCP.0000000000000614